Corient Private Wealth’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
Corient Private Wealth's ABUS Position: Q3 2026 in Review
Corient Private Wealth opened a new position in Arbutus Biopharma (ABUS) in Q3 2026: 19,801 shares worth $94.6K. The stake represents ﹤0.01% of the portfolio and ranks #3148 among its holdings.
216 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.
- Corient Private Wealth held 19,801 shares of Arbutus Biopharma worth $94.6K as of Q3 2026.
- Arbutus Biopharma was a new Corient Private Wealth position in Q3 2026.
- Arbutus Biopharma made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #3148 holding.
- 216 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.
Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.